Breaking News
0
Ad-Free Version. Upgrade your Investing.com experience. Save up to 40% More details
Close

Atossa Genetics Inc (ATOS)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Atossa Genetics's earnings

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
2.780 -0.050    -1.77%
15:59:59 - Closed. Currency in USD ( Disclaimer )
After Hours
2.760
-0.020
-0.719%
19:36:42 - Real-time Data
Type:  Equity
Market:  United States
ISIN:  US04962H5063 
CUSIP:  04962H506
  • Volume: 3,397,599
  • Bid/Ask: 2.750 / 2.770
  • Day's Range: 2.690 - 2.810
Atossa Genetics 2.780 -0.050 -1.77%

Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

ATOS Comments

Write your thoughts about Atossa Genetics Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Jacky Lee
Jacky Lee Oct 07, 2021 12:45PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
No volume
Paco Bv
Pacob Oct 07, 2021 11:24AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
guys, don't be fooled, ATOS must close the gap up to $5.34 at least
Albert Hee
Albert Hee Oct 07, 2021 10:26AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
,🚀🚀🚀🚀🚀🚀
Albert Hee
Albert Hee Oct 07, 2021 10:26AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
,🚀🚀🚀🚀🚀🚀
Albert Hee
Albert Hee Oct 07, 2021 10:26AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
,🚀🚀🚀🚀🚀🚀
Paco Bv
Pacob Oct 06, 2021 5:39PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Now shorties time to think about that Short Float of 18.70% (23,674,398 shares more or less) sayonara baby 💪🇺🇸💪
Paco Bv
Pacob Oct 06, 2021 5:13PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
🥳🥳🥳
Paco Bv
Pacob Oct 06, 2021 5:09PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
On September 7, 2021, Atossa Therapeutics, Inc. (the "Company”) convened a Special Meeting of Stockholders (the "Special Meeting”) for the purpose of voting on a proposal to increase authorized shares of common stock by 100 million. As of that date, the proposal did not have sufficient yes votes to pass so the Special Meeting was adjourned until October 7, 2021 to allow additional time for voting. As of October 6, 2021, approximately 58,445,262 votes were cast in favor of the proposal which is approximately 46.2% of the outstanding shares of common stock on the record date. A majority of the issued and outstanding shares of common stock on the record date must vote in favor of the proposal for it to pass. Because the proposal has not garnered sufficient votes to pass, the Company is withdrawing the proposal and is cancelling the Special Meeting.
Paco Bv
Pacob Oct 06, 2021 5:09PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Fasten seat belts 💥🚀 🤑🥳🥳🥳
Paco Bv
Pacob Sep 30, 2021 9:51AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
SEATTLE, Sept. 30, 2021 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS), a clinical stage biopharmaceutical company seeking to discover and develop innovative medicines in areas of significant unmet medical need in oncology and infectious diseases with a current focus on breast cancer and COVID-19, today announces it has begun to enroll participants in its clinical study of AT-H201 in Australia. The nebulized formulation, AT-H201, is being developed as an inhalation therapy for moderately to severely-ill hospitalized COVID-19 patients and for "long-haul" patients with post-infection pulmonary disease.
Paco Bv
Pacob Sep 14, 2021 5:17PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
that Dr. Quay thinks he is cute and all the rest are inmenselly i~diot~s and our hole in the back sized the Grand Canyon, very nice of him
Paco Bv
Pacob Sep 08, 2021 3:36AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
There're not enough votes nor will there be, price should recover $5,3 as soon as possible to close the gap, the fair behavior. If executives intention is their own enrichment at any costs, let them BUY the shares spilled at the open market from US. If they force the siege for their illicit profit, they'll be sued in an organized and massive way
Paco Bv
Pacob Sep 02, 2021 10:59AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Atossa Therapeutics Receives Approval from the Swedish Ethics Review Authority to Initiate a Phase 2 Clinical Study of Oral Endoxifen to Reduce Mammographic Breast Density in Sweden
JJ JJ
JJ JJ Aug 04, 2021 1:27PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
bahunwhere did you see that?
Bahun Gurung
Bahun Gurung Aug 03, 2021 5:33AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
they want to rip us off by adding 100 million more common shares in september almost double diluition from what it is already
Ahmet Kok
Ahmet Kok Aug 03, 2021 4:14AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Walk run fly
Bahun Gurung
Bahun Gurung Jul 30, 2021 4:43PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
unbelivable 24% down what an attack from over 3x on my money on this stock to -ve in a month. this sucksss didnt take out my profit thinking this will hit $60 n make me a fortune 🤦🤦🤦
JJ JJ
JJ JJ Jul 30, 2021 4:43PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
I pulled out 2 early
Mykel Wndsrf
Mykel Jul 30, 2021 2:39PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
ma(200)  2.75  ?  :-)
Joshua Sonoma
Joshua Sonoma Jul 30, 2021 1:21PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Shakedown to $2.20 about to be concluded next week. Thank you for your money.
Jacky Lee
Jacky Lee Jul 30, 2021 10:27AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Manipulation at its best. I am even wondering is the company trying to colluding with shorties so they can subscribe the new shares cheap to cover their short position. Lets vote this dem thing down
Jacky Lee
Jacky Lee Jul 28, 2021 2:15PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Will the company consider to pay dividend so the shorts r forced to cover? Even just half a sen. Price is overly depressed by the shorts activity
David Cooper
David Cooper Jul 25, 2021 10:14PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
2nd Highest Traded Unusual Options Activity
Sharon Martin
Sharon Martin Jul 21, 2021 3:48PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
YES!!!
Ahmet Kok
Ahmet Kok Jul 21, 2021 3:35PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Are you ready for good news?
Reagan Tang
Market_Surfer Jul 21, 2021 3:35PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Whats thr good news
Luis Ortiz
Luis Ortiz Jul 20, 2021 3:46PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Here We go.......
Jaime Peniche
Jaime Peniche Jul 20, 2021 3:46PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
yes, go to the ********:S
Jacky Lee
Jacky Lee Jul 20, 2021 10:51AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Hibernation
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review

Make Smart Decisions.
Research, evaluate, and invest with unique market insights

Volatile markets create opportunities.
Don’t miss out.

Investing Insights
Investing Insights
Investing Insights

Read More

Invest with knowledge

Leverage the wisdom of financial experts and seize market opportunities.

  • Generate investment ideas based on leading Wall Street analyst recommendations.

  • Research trending stocks using 6 unique market factors.

  • Receive market updates in our Insights Newsletter.

Why Investing Insights

5 ways to boost your research

  • Objective stock score based on 6 market factors

  • Wall Street analyst price targets and ratings

  • Stock sentiment by bloggers, insiders, and financial gurus

  • News sentiment and score for thousands of stocks

  • Simplified screener with 3 ways to research investment ideas

  • Objective stock score based on 6 market factors

  • Wall Street analyst price targets and ratings

  • Stock sentiment by bloggers, insiders, and financial gurus

  • News sentiment and score for thousands of stocks

  • Simplified screener with 3 ways to research investment ideas

  • Objective stock score based on 6 market factors

  • Wall Street analyst price targets and ratings

  • Stock sentiment by bloggers, insiders, and financial gurus

  • News sentiment and score for thousands of stocks

  • Simplified screener with 3 ways to research investment ideas

Stay Ahead. Learn From the Pros.

For the stocks you research, we’ll bring you insights from

Questions & Answers

  • What is Investing Insights?

    Investing Insights is a premium service that provides you with actionable insights from thousands of financial experts that cover the US stock market. Find out which stocks Wall Street analysts, insiders, financial bloggers, hedge fund managers and individual investors are recommending. Investing Insights is available only on our website. Canadian and UK stock markets will soon be added.

  • What is "Smart Score"?

    Smart Score is a powerful scoring system that ranks stocks on a scale of 1-10 based on 6 unique market factors. Smart Score is updated every evening after the market closes, 5 days a week.

  • Can I try Investing Insights for free?

    Yes. You can try Investing Insights for 14 days free of charge.
    The trial period will be followed by a paid subscription. To avoid being charged simply contact our support to cancel the subscription before the trial period ends.
    Please notice that purchases made through PayPal might be subjected to a temporary authorization.

  • How do I cancel my Investing Insights premium subscription?

    In order to cancel your subscription, please contact our support with your registered email or reference number and one of our agents will be happy to assist you.

  • Will I get notified before my subscription renewal?

    Our subscription has automatic renewal, meaning that when you reach the subscription end date, you will be charged automatically and your subscription will be extended. You can cancel your subscription anytime by following the instructions in the answer to the "How do I cancel my Investing Insights subscription" question. The subscription will remain active for the duration of the paid period.

  • What are the available payment methods?

    We accept all major credit cards and debit cards, including Visa, Mastercard, American Express, Discover, JCB, and Diners. Additional payment options may be available in your specific location

Got more questions?

We hope you found the answers you were looking for. You can read more about Insights here. Please go to the Investing Help Center for further information.

By subscribing you agree to TipRanks' Terms and Conditions and Privacy Policy

Powered by
Continue with Google
or
Sign up with Email